Contents
Financial Highlights
002
Performance Highlights
003
Financial and Operational Review
005
Capital Risk Management
006
Market Review and Outlook
007
Trust Structure
012
Growth Strategy
013
Organisation Chart
014
Letter to Unitholders
015
Board of Directors
018
Senior Management of the
Trustee-Manager, Singapore
020
RHT
Senior Management Team, India
021
The Year in Perspective
023
Geographically Diversified
Asset Portfolio
026
Portfolio Summary
028
Corporate Sustainability Report
043
Corporate Governance Report
045
Annual Financial Statements
067
Statistics of Unitholdings
133
Notice of Annual General Meeting
of Unitholders
135
Corporate Information
138
Proxy Form
139
Religare Health Trust (“RHT”) is the first business trust listed on
the Singapore Exchange Securities Trading Limited (“SGX-ST”)
with India based healthcare assets.
Our investment mandate is principally to invest in medical and
healthcare assets and services in Asia, Australasia and emerging
markets in the rest of the world. RHT may also develop medical
and healthcare assets.
RHT has a portfolio of strategically located Clinical
Establishments* and Operating Hospitals across India, currently
comprising 12 Clinical Establishments, four Greenfield Clinical
Establishments and two Operating Hospitals. The value of these
assets is approximately S$1,129 million
^
as at 31 March 2016.
About Religare Health Trust
We endeavor to provide regular
and stable returns to investors by
investing into healthcare assets
providing attractive yields with
a potential for long term growth.
* Clinical Establishment refers to a fully centrally air-conditioned institution
established and specifically customised and fitted with all fixtures, fittings,
medical equipment and infrastructure required for running and operating a
hospital, offering (1) services for diagnosis and treatment for illness, disease,
injury, deformity and/or abnormality; (2) diagnosis of diseases through
radiological and other diagnostic and investigative services with the aid of
laboratory or other medical equipment; and (3) beds for in-patient treatment.
^
Based on an exchange rate of S$1 = INR 49.20 as at 31 March 2016.
